News Releases News Releases HOME HOME



November 29, 2004

For itchy or red eyes due to dust, dirt or pollen
Release of "IRIS AG Cool,"
New Eye Drops with Two Anti-inflammatory Agents




Taisho Pharmaceutical Co., Ltd. (President: Akira Uehara) will release new eye drops, IRIS AG Cool, on November 30. This product effectively eases itchy or red eyes and provides an immediate and pleasantly refreshing sensation. 

When antigens such as dust, dirt and pollen enter the body, the body reacts by producing antibodies. When antibodies bind to antigens, chemical substances such as histamine are released, which can cause itchy and/or red eyes. 

IRIS AG Cool contains two anti-inflammatory agents (epsilon aminocaproic acid and dipotassium glycyrrhizinate) and the standard maximum amount of tetrahydrozoline hydrochloride, which is a decongestant. These active ingredients effectively alleviate eye inflammation and red eyes. In addition, vitamin B6, taurine and sodium chondroitin sulfate provide nutrients to the eyes, improve metabolism in damaged eyes, and prevent eye diseases. IRIS AG Cool provides a satisfying and pleasantly refreshing sensation to ease itchy or inflamed eyes.

Product features
- Contains two anti-inflammatory agents, which alleviate inflammation
- Contains the standard maximum amount of decongestant, which alleviates red eyes
- Contains vitamin B6, which improves eye metabolism
- Easy-to-understand information is provided on the package
- Provides a pleasantly refreshing sensation

Product specification

Product name IRIS AG Cool
Suggested retail price ¥1,260 (¥1,200 product + ¥60 tax)
Ingredients
Tetrahydrozoline hydrochloride 0.05%
Epsilon aminocaproic acid 1.0%
Dipotassium glycyrrhizinate 0.25%
Chlorpheniramine maleate 0.03%
Pyridoxine hydrochloride (vitamin B6) 0.1%
Aminoethylsulfonic acid (taurine) 1.0%
Sodium chondroitin sulfate 0.1%
Indications Itchy eyes, conjunctival redness, prevention of eye diseases (e.g. after swimming, or when dust or perspiration enter the eyes), blepharitis (a sore on the eyelid), bleary eyes (when there is too much mucus), ophthalmia due to ultraviolet rays or other damaging light (e.g. snow blindness), eyestrain, and discomfort caused by hard contact lenses.
Dosage Apply two to three drops, three to six times a day.
Date of sale November 30, 2004
Expected sales ¥300 million(one year from date of sale)